Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors

In this online program based on a series of CLL Webinars experts discuss evidence-based best practices in using BTK inhibitors to treat patients with CLL. Watch the on-demand Webcast and download the slides now.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca